Moral distress arises not only from organizational constraints on moral action but also from the environmental impacts of health care and climate change.
AMA J Ethics. 2017;19(6):617-628. doi:
10.1001/journalofethics.2017.19.6.mhst1-1706.
Jayant Menon, MD, MEng and Daniel J. Riskin, MD, MBA
The authors describe a historical pattern in which a set of enabling technologies facilitates rapid advances in medical practice, resulting in recognition of new ethical challenges and a decades-long struggle to resolve them.
The continuance of public and institutional support for medical research after the publicized deaths of human research participants in the 1950s contrasts sharply with the disciplining of institutions responsible for two such deaths in recent decades, which suggests that medical research participants are no longer receiving public recognition for their contributions to science.
AMA J Ethics. 2015;17(12):1166-1171. doi:
10.1001/journalofethics.2015.17.12.mhst1-1512.
Those charged by the ACA health reform act to identify best clinical practices that are evidence-based and applicable across diverse populations can learn much from the experience of the Medicare-funded End Stage Renal Disease Program.
Primary materials including interviews with some of the volunteer subjects provide information on the experiments into the pathogenic mechanism of yellow fever.